Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. The firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. The company is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company is engaged in developing MosaiQ, which is its technology platform. The firm develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Industry: In Vitro & In Vivo Diagnostic Substances